Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia with Novel Targeted Agents

Tumor lysis syndrome (TLS) is an uncommon but potentially life‐threatening complication associated with the treatment of some cancers. If left untreated, TLS may result in acute renal failure, cardiac dysrhythmia, neurologic complications, seizures, or death. Tumor lysis syndrome is most commonly ob...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Cheson, Bruce D., Heitner Enschede, Sari, Cerri, Elisa, Desai, Monali, Potluri, Jalaja, Lamanna, Nicole, Tam, Constantine
Format: Artigo
Idioma:Inglês
Publicat: AlphaMed Press 2017
Matèries:
Academia‐Pharma Intersect: Hematologic Malignancies
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5679833/
https://ncbi.nlm.nih.gov/pubmed/28851760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0055
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars